McMillan Office »

Vertex Pharmaceuticals Incorporated shares owned by McMillan Office

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by McMillan Office from 13F filings

Historical chart of McMillan Office investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by McMillan Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by McMillan Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $134k 300 446.54

More positions owned by McMillan Office

Alphabet Common, Large Cap (GOOGL)
Apple Common, Large Cap (AAPL)
Alphabet Common, Large Cap (GOOG)
Invesco Qqq Tr Common, Large Cap Growth (QQQ)
Microsoft Corp Common, Large Cap (MSFT)
Meta Platforms Common, Large Cap (META)
Amazon.com Common, Large Cap (AMZN)
Abbvie Common, Large Cap Value (ABBV)
Rtx Corporation Common, Large Cap (RTX)
Exxon Mobil Corp Common, Large Cap Value (XOM)
Jpmorgan Chase & Co Common, Large Cap Value (JPM)
Cisco Systems Common, Large Cap Value (CSCO)
Johnson & Johnson Common, Large Cap Value (JNJ)
American Express Company Common, Large Cap Value (AXP)
Pepsico Common, Large Cap Value (PEP)

View all positions for McMillan Office

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Geode Capital Management
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Wellington Management Company
Victory Capital Management
Jennison Associates
Norges Bank Investment Management
Ubs Global Asset Management Americas
ClearBridge Advisors

View all funds holding Vertex Pharmaceuticals Incorporated